We observed that SENP3 is up-regulated in livers from NAFLD patients and HFD fed rats in vivo, and after loading hepatocytes with free fatty acids (FFA) in vitro. This evidence concerns the gene SENP3 and metabolic dysfunction-associated steatotic liver disease.